Long term observations of lymphocyte subsets in psoriatic patients treated with fumaric acid esters;Verlaufsbeobachtungen der Lymphozytensubpopulation bei Psoriasis-Patienten unter oraler Therapie mit Fumaraten

Aktuelle Dermatologie

Volumn 22, Issue 9-10, 1996, Pages 272-277

  Altmeyer, P ^a   Hoxtermann S ^a   Auer, T ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FUMADERM; FUMARIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; ORAL DRUG ADMINISTRATION; PSORIASIS;

EID: 0029826492     PISSN: 03402541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Altmeyer, P., U. Matthes, F. M. Pawlak, K. Hoffmann, P. J. Frosch, P. Ruppert, S. W. Wassilew, T. Horn, H. W. Kreysel, G. Lutz, J. Barth, I. Ritzschel, R. K. Joshi: Anti-psoriatic effect of fumaric acid derivatives: results of a multicenter double-blind study in 100 patients. J. Am. Acad. Dermatol. 30 (1994) 977-981
2. Bacharach-Buhles, M., F. M. Pawlak, U. Matthes, R. K. Joshi, P. Altmeyer: Fumaric acid esters (FAEs) suppress CD 15- and ODP 4-positive cells in Psoriasis. Acta dermatol-venereol, Stockh., Suppl. 186 (1994) 79-82
3. Baker, B. S., A. F. Swain, H. Valdimarsson, L. Fry: T-cell subpopulations in the blood and skin of patients with psoriasis. Br. J. Dermatol. 110 (1984) 37-44
4. Bayard, W., T. Hunziker, A. Krebs, P. Speiser, R. Joshi: Perorale Langzeitbehandlung der Psoriasis mit Fumarsäurederivaten. Hautarzt 38 (1987) 279-285
5. Kirchgessner, M., F. X. Roth: Verdaulichkeit und Bilanz von Protein, Energie und einigen Mineralstoffen bei Fumarsäurezulagen an Ferkeln. Z. Tierphysiol. Tierernährg. Futtermittelkde. 44 (1980) 239-246
6. Matthes, U., R. Hartwig, P. Altmeyer: Der antipsoriatische Effekt der Fumarsäurederivate. Akt. Dermatol. 21 (1995) 40-44
7. Nieboer, P. H., D. de Hoop, A. C. van Loenen, P. N. J. J. Langendyk, E. van Dijk: Systemic therapy with fumaric acid derivatives: new possibilities in the treatment of psoriasis. J. Am. Acad. Dermatol. 20 (1989) 601-608
8. Nugteren-Huying, W. M., J. G. van der Schroeff, J. Hermans, D. Suurmond: Fumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled study. J. Am. Acad. Dermatol. 22 (1990) 311-312
9. Onuma, S.: Immunhistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J. Dermatol. 21, 4 (1994) 223-232
10. Petres, J., K. W. Kalkoff, D. Baron, R. Geiger, I. Kunick: Der Einfluß von Fumarsäuremonoethylester auf die Nucleinsäure- und Proteinsynthese PHA-stimuherter menschlicher Lymphozyten. Arch. Derm. Forsch. 251 (1975) 295-300
11. Roodnat, J. I., M. H. L. Christiaans, W. M. Nugteren-Huying, J. G. van der Schroeff, P. van der Zouwen, B. H. C. Stricker, J. J. Weening, P. C. Chang: Akute Niereninsuffizienz bei der Behandlung der Psoriasis mit Fumarsäure-Estern. Schweiz. med. Wschr. 119 (1989) 826-830
12. Schweckendiek, W.: Heilung von Psoriasis vulgaris. Med. Mschr. 13 (1959) 103-104
13. Sebök, B., B. Bonnekoh, J. Geisle, G. Mahrle: Antiproliferative and cytotoxic profiles of antipsoriatic fumaric acid derivates in keratinocyte cultures. Eur. J. Pharm. 270 (1994) 79-87
14. Sebök, B., B. Bonnekoh, G. Mahrle: IL-1-alpha induced expression of ICAM-1 on cultures hyperproliferative keratinocytes: suppression by antipsoriatic dimethylfumarate. Int. J. Dermatol. 33, 5 (1994) 367-370
15. Thio, H. B., T. P. L. Zomerdijk, C. Oudshoorn, J. Kempenaar, P. H. Nibbering, J. G. van der Schroeff, M. Ponec: Furnaric acid derivatives evoke a transient increase in intracellular free calcium concentration and inhibit the proliferation of human keratinocytes. Br. J. Dermatol. 131 (1994) 856-861
16. Validimarsson, H., B. S. Baker, I. Jonsdottir, L. Fry: Psoriasis, a disease of abnormal keratinocyte proliferation induced by T-lymphocytes. Immunol. Today 7 (1986) 256-259